Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies

EMBO Journal

Volumn 19, Issue 15, 2000, Pages 4123-4133

  Zong, Rui Ting ^a   Das, Chhaya ^a   Tucker, Philip W ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Autoantigen; Nuclear matrix attachment; PML nuclear bodies; Transcription regulation

Indexed keywords

AUTOANTIGEN; B CELL REGULATOR OF IGH TRANSCRIPTION; IMMUNOGLOBULIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS INCLUSION BODY; CELL NUCLEUS MATRIX; CONTROLLED STUDY; ENHANCER REGION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

DROMAIUS NOVAEHOLLANDIAE;

EID: 0034254161     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.15.4123     Document Type: Article

References (64)

1. Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Szekely, L., Hellin, K. and Pelicci, P.G. (1998) The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell biol., 18, 1084-1093.
2. Ascoli, C.A. and Maul, G.G. (1991) Identification of a novel nuclear domain. J. Cell Biol., 112, 785-795.
3. Bell, A., Boyes, J., Chung, J., Pikaart, M., Prioleau, M.-N., Recilias, F., Saitoh, N. and Felsenfeld, G. (1998) The establishment of active chromatin domains. Cold Spring Harb. Symp. Quant. Biol., 63, 509-514.
4. Bloch, D.B., de la Monte, S.M., Guigaouri, P., Fllippov, M.M. and Bloch, K.D. (1996) Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem., 46, 29198-29204.
5. Bloch, D.B., Chiche, J.D., Orth, D., de la Monte, S.M., Rosenzweig, A. and Bloch, K.D. (1999) Structural and functional heterogeneity of nuclear bodies. Mol. Cell. Biol, 19, 4423-4430.
6. Boddy, M.N., Howe, K., Etkin, L.D., Solomon, E. and Freemon, P.S. (1996) PIC-1, a novel ubiquitin-like protein which interacts with the PML component of a mulitprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene, 13, 971-982.
7. Borden, K.L.B., Dwyer, E.J.C. and Salvato, M.S. (1998) An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukamia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol., 72, 758-766.
8. Chang, K., Fan, Y., Andreeff, M., Liu, J. and Mu, Z. (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood, 85, 3646-3653.
9. Dent, A.L., Yewdell, J., Puvion-Dutilleul, F., Koken, M.H.M., de The, H. and Staudt, L.M. (1996) LYSp100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood, 88, 1423-1436.
10. Desbois, C., Rousset, R., Bantignies, F. and Jalinot, P. (1996) Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science, 273, 951-953.
11. Deshaies, R.J. (1995) Make it or break it: the role of ubiquitin-dependent protein lysis in cellular regulation. Trends Cell Biol., 5, 428-434.
12. Desterro, J.M.P., Rodriguez, M.S. and Hay, R.T. (1998) SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell, 2, 233-239.
13. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract isolated from mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
14. Doucas, V. and Evans, R.M. (1996) The PML nuclear compartment andcancer. Biochim. Biophys. Acta, 1288, M25-M29.
15. Doucas, V., Ishov, A.M., Romo, A., Juguilon, J., Weltzman, M., Evans, R.M. and Maul, G.G. (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev., 10, 196-207.
16. Dyck, J.A., Maul, G.G., Miller, W.H.J., Chen, J.D., Kakizuka, A. and Evans, R.M. (1994) A novel macromolecular structure is a target of the promyelacytic - retinoic acid receptor oncoprotein. Cell, 76, 333-343.
17. Forrester, W.C., van Genderen, C., Jenuwein, T. and Grosschedl, R. (1994) Dependence of enhancer-mediated transcription of the immunoglobulin gene on nuclear matrix attachment regions. Science, 265, 1221-1225.
18. Gibbons, R.J. et al. (1997) Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nature Genet., 17, 146-148.
19. Grignani, F. et al. (1996) Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion of the PML protein dimerization and RARα DNA binding domains. EMBO J., 15, 4949-4958.
20. Grignani, F. et al. (1998) Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature, 391, 815-818.
21. Gstaiger, M., Knoepfl, L., Georgiev, O., Schaffner, W. and Hovens, C.M. (1995) A B-cell coactivator of octamer-binding transcription factors. Nature, 373, 360-362.
22. Haynes, S.R., Dollard, C., Winston, F., Beck, S., Trowsdale, J. and Dawid, I.B. (1992) The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res., 20, 2603.
23. Herrscher, R.F., Kaplan, M.H., Lelsz, D.L., Scheuermann, R.H. and Tucker, P.W. (1995) The immunoglobulin heavy-chain matrix associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev., 9, 3067-3082.
24. Ishov, A.M. and Maul, G.G. (1996) The periphery of nuclear domain 10 (ND10) as a site of DNA virus deposition. J. Cell Biol., 134, 815-826.
25. Käs, E., Poljak, L., Adachi, Y. and Laemmli, U.K. (1993) A model for chromatin opening: stimulation of topoisomerase II and restriction enzyme cleavage of chromatin by distamycin. EMBO J., 12, 115-126.
26. Koken, M.H.M. et al. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J., 13, 1073-1083.
27. Korioth, F., Gleffers, C., Maul, G.G. and Frey, J. (1995) Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and Interferon treatment. J. Cell Biol., 130, 1-13.
28. Laemmli, U.K., Kas, E., Poljak, L. and Adachi, Y. (1992) Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev., 2, 275-285.
29. Lamond, A.I. and Earnshaw, W.C. (1998) Structure and function in the nucleus. Science, 280, 547-553.
30. Lehming, N., Saux, A.L., Schuller, J. and Patshne, M. (1998) Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl Acad. Sci. USA, 95, 7322-7326.
31. Lin, R.J., Nagy, L., Inoue, S., Shao, W., Miller, W.H.,Jr and Evans, R.M. (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature, 391, 811-814.
32. Matilla, A.B., Koshy, T., Cummings, C.J., Isobe, T., Orr, H.T. and Zoghbi, H.Y. (1998) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature, 389, 974-978.
33. Maul, G.G. and Everett, R.D. (1994) The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol., 75, 1223-1233.
34. Maul, G.G., Guldner, H.H. and Spvack, J.G. (1993) Modification of discrete nuclear domains induced by herpes simplex virus type-1 immediate early gene 1 product (ICP0). J. Gen. Virol., 74, 2679-2690.
35. Maul, G.G., Yu, E., Ishov, A.M. and Epstein, A.L. (1995) Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell. Biochem., 59, 489-513.
36. McKnight, R.A., Shamay, A., Sankaran, L., Wall, R.J. and Henninghausen,L. (1992) Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc. Natl Acad. Sci. USA, 89, 6943-6947.
37. 1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear matrix. Cell, 65, 381-393.
38. Mu, Z., Chin, K.V., Liu, J.H., Lozano, G. and Chang, K.S. (1994) PML, a growth-suppressor disrupted in acute promyelocytic leukemia. Mol. Cell, Biol., 14, 6858-6867.
39. Muller, S., Matunis, M.J. and Dejean, A. (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J., 17, 61-70.
40. Oancea, A.E., Berru, M. and Shulman, M.J. (1997) Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions. Mol. Cell. Bio., 17, 2658-2668.
41. Pemov, A., Bavykin, S. and Hamlin, J.L. (1998) Attachment to the nuclear matrix mediates specific alterations in chromatin structure. Proc. Natl Acad. Sci. USA, 95, 14757-14762.
42. Peterson, C.L. and Tamkun, J.W. (1995) The SWI - SNF complex: a chromatin remodeling machine? Trends Biochem. Sci., 20, 143-146.
43. Puvion-Dutilleul, F., Chelbi-Alix, M.K., Koken, M., Quignon, F., Puvion, E. and de The,H. (1995). Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body associated PML protein. Exp. Cell Res., 218, 9-16.
44. Reyes, J.C, Muchardt, C. and Yaniv, M. (1997) Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol., 137, 263-274.
45. Schnitzler, G.R., Sif, S. and Kingston, R.E. (1998) A model for chromatin remodeling by the SWI/SNF family. Cold Spring Harb. Symp. Quant. Biol., 63, 535-543.
46. Schwarz, S.E., Matuschewsk, K., Liakopoulos, D., Scheftner, M. and Jentsch, S. (1998) The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc. Natl Acad. Sci. USA, 95, 560-564.
47. Seeler, J.-S., Marchio, A., Sitterlin, D., Transy, C. and Dejean, A. (1998) Interaction of Sp100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl Acad. Sci. USA, 95, 7316-7321.
48. Singh, L., Panicker, S.G., Nagaraj, R. and Majumdar, K.C. (1994) Banded krait micro-satellite (Bkm)-associated Y chromosome-specific repetitive DNA in mouse. Nucleic Adds Res., 22, 2289-2295.
49. Skinner, P.J., Koshy, B.T., Cummings, C.J., Klement, I.A., Helin, K., Servadio, A., Zoghbi, H.Y. and Orr, H.T. (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature, 389, 971-974.
50. Spector, D.L. (1993) Macromolecular domains within the cell nucleus. Annu. Rev. Cell. Biol., 9, 265-315.
51. Stein, G.S., van Wijnen, A.J., Stein, J.L., Lian, J.B., Pockwinse, S. and McNeil, S. (1998) Interrelationships of nuclear structure and transcriptional control: functional consequences of being in the right place at the right time. J. Cell. Biochem., 70, 200-212.
52. Sternsdorf, T., Grotzinger, T., Jensen, K. and Will, H. (1997) Nuclear dots: actors on many stages, Immunoblotting, 198, 307-331.
53. Stief, A., Winter, D.M., Stratling, W.H. and Sippel, A.E. (1989) A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature, 341, 343-345.
54. Szekely, I., Pokrovskaja, K., Jiang, W.A., de The, H., Ringertz, N., Klein, G. (1996) The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol, 70, 2562-2568.
55. Szostecki, C., Guldner, H.H., Netter, H.J. and Will, H. (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol., 145, 4338-4347.
56. Terris, B., Baldin, V., Dubois, S., Degott, C., Flejou, J.F., Henin, D. and Dejean, A. (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res., 55, 1590-1597.
57. Wang, Z., Goldstein, A., Zong, R., Lin, D., Neufeld, EJ., Scheuermann, R.H. and Tucker, P.W. (1999) Cux/CDP homeoprotein is a component of NF-μNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the Bright transcription activator. Mol. Cell. Biol., 19, 284-295.
58. Webb, C.F., Das, C, Eaton, S., Calame, K. and Tucker, P.W. (1991) Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol. Cell. Biol., 11, 5197-5205.
59. Webb, C.F., Smith, E.A., Buchanan, K.L., Smithson, G. and Dou, S. (1998) Expression of Bright at two distinct stages of B lymphocyte development. J. Immunol., 160, 4747-4754.
60. Webb, C. et al. (1999) Differential regulation of immunoglobulin gene transcription via nuclear matrix associated regions. Cold Spring Harb. Symp. Quant. Biol., 64, 109-118.
61. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmofonseca, M., Lamond, A. and Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell, 76, 345-356.
62. Xie, K., Lambie, E. and Snyder, M. (1993) Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol., 13, 6170-6179.
63. Zong, R. and Scheuermann, R.H. (1995) Mutually exclusive interaction of a novel MAR-binding protein and the NF-μNR enhancer repressor: implications for regulation of immunoglobulin heavy-chain expression. J. Biol. Client., 270, 24010-24018.
64. Zhu, Z., Cai, W. and Schafter, P.A. (1994) Cooperatively among herpes simplex virus type I immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J. Virol., 68, 3027-3040.